ANAVEX LIFE SCIENCES CORP. Other Noncash Income (Expense)
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Other Noncash Income (Expense) of $2.83 thousand for the 3-month period ending 2015-12-31, per its 10-Q filed 2016-02-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2016-02-08
- ANAVEX LIFE SCIENCES CORP. other noncash income (expense) for the quarter ending 2015-12-31 was $2.83K, a 49.58% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. other noncash income (expense) for the quarter ending 2014-12-31 was $5.61K.
- ANAVEX LIFE SCIENCES CORP. other noncash income (expense) for fiscal 2015 was $18.68K, a 0.61% decline from fiscal 2014.
- ANAVEX LIFE SCIENCES CORP. other noncash income (expense) for fiscal 2014 was $18.80K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 12 month |
|---|---|---|
| 2015-12-31 | $2.83K 10-Q · filed 2016-02-08 | |
| 2015-09-30 | $18.68K 10-K · filed 2015-12-29 | |
| 2014-12-31 | $5.61K 10-Q · filed 2016-02-08 | |
| 2014-09-30 | $18.80K 10-K · filed 2015-12-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |